Department of Nutritional Toxicology, German Institute of Human Nutrition (DIfE) Potsdam Rehbruecke, 14558 Nuthetal, Germany.
Environ Mol Mutagen. 2010 Jan;51(1):23-30. doi: 10.1002/em.20503.
Genetic engineering of target cells for investigating the genotoxicity associated with specific xenobiotic-metabolizing enzymes is useful for elucidating metabolic activation and inactivation processes. We constructed a V79-derived cell line expressing both human cytochrome P450 (CYP) 2E1 and human sulfotransferase (SULT) 1A1. We previously reported that this cell line (V79-hCYP2E1-hSULT1A1) efficiently activates various important pro-genotoxicants. Here we present data on the expression level and stability of the heterologous enzymes, measured by immunoblotting, enzyme activities, and mutagenic responses to CYP2E1- and SULT1A1-dependent promutagens. Unexpectedly, these cells demonstrated greatly elevated spontaneous gene mutation frequencies (determined at the Hprt locus), and elevated frequencies of sister chromatid exchange, as compared with control V79 cells and V79-derived lines engineered for other enzymes. Therefore, V79-hCYP2E1-hSULT1A1 cells require regular cleansing in aminopterin-containing medium when used for Hprt gene mutation assays. In a 4-week time course without such selection, V79-hCYP2E1-hSULT1A1 demonstrated a progressive increase in the spontaneous mutant frequency from 2.9 to 155 x 10(-6). This phenomenon was moderately, strongly, and completely prohibited in the presence of CYP2E1 inhibitor 1-aminobenzotriazole, SULT1A1 inhibitor pentachlorophenol and both in combination, respectively. This protection indicates that the enhanced spontaneous mutagenicity involves the activity of the expressed enzymes rather than being caused by an accidental genetic alteration that might have occurred during transfection. We postulate that human CYP2E1 and SULT1A1 activate an endogenous cellular molecule or a medium component to become mutagenic. It will be challenging to identify this compound and to see whether it is involved in spontaneous mutagenesis and carcinogenesis in vivo.
目的细胞的基因工程用于研究与特定外源物质代谢酶相关的遗传毒性对于阐明代谢激活和失活过程是有用的。我们构建了一个表达人细胞色素 P450(CYP)2E1 和人磺基转移酶(SULT)1A1 的 V79 衍生细胞系。我们之前报道过,该细胞系(V79-hCYP2E1-hSULT1A1)能够有效地激活各种重要的前遗传毒性物质。在这里,我们提供了通过免疫印迹、酶活性和 CYP2E1 和 SULT1A1 依赖性前诱变剂的致突变反应来测量的异源酶的表达水平和稳定性的数据。出乎意料的是,与对照 V79 细胞和为其他酶工程化的 V79 衍生系相比,这些细胞显示出大大增加的自发基因突变频率(在 Hprt 基因座上测定)和姐妹染色单体交换频率。因此,当用于 Hprt 基因突变测定时,V79-hCYP2E1-hSULT1A1 细胞需要在含氨基喋呤的培养基中定期清洗。在没有这种选择的 4 周时间过程中,V79-hCYP2E1-hSULT1A1 显示自发突变频率从 2.9 增加到 155 x 10(-6)。在 CYP2E1 抑制剂 1-氨基苯并三唑、SULT1A1 抑制剂五氯苯酚和两者的组合存在下,分别适度、强烈和完全抑制了这种现象。这种保护表明,增强的自发致突变性涉及表达酶的活性,而不是由转染过程中可能发生的偶然遗传改变引起的。我们假设人 CYP2E1 和 SULT1A1 激活内源性细胞分子或培养基成分成为致突变剂。鉴定这种化合物并观察它是否参与体内自发突变和致癌作用将是具有挑战性的。